Cardiovascular Disease Resources

Cardiovascular [heart] disease describes a range of conditions that affect your heart. Heart diseases include:

• Blood vessel disease, such as coronary artery disease.
• Heart rhythm problems (arrhythmias).
• Heart defects you're born with (congenital heart defects).
• Heart valve disease.
• Disease of the heart muscle.
• Heart infection.¹

AMCP is pleased to work with Pfizer to offer these resources to you. 

Journal of Managed Care + Specialty Pharmacy

• Add-On Therapies in Cardiovascular Disease: Reviewing ICER’s Report and the Potential Effect on Payers. Journal of Managed Care + Specialty Pharmacy, 2020 Jun;26(6):786-788.

• Optimization of Lipid-Lowering Therapy for High Cardiovascular Risk Patients Through Electronic Medical Record Reporting and Pharmacist Evaluation. Journal of Managed Care + Specialty Pharmacy, 2020 Aug;26(8):1010-1016.

Additional Publications

• Long-term cardiovascular outcomes of COVID-19. Yan Xie, Evan Xu, Benjamin Bowe, et al. Nat Med. 2022 Mar 2. doi: 10.1038/s41591-022-01689-3. 
• P2X7 Receptors: An Untapped Target for the Management of Cardiovascular Disease. Shokoples B, Paradis P, Schiffrin E. Arterioscler Thromb Vasc Biol. 2021 Jan. doi: 10.1161/ATVBAHA.120.315116.
• Circadian influence on inflammatory response during cardiovascular disease. 
  Aziz I, McMahon A, Friedman D, et al. Curr Opin Pharmacol. 2021 Apr. doi: 10.1016/j.coph.2020.11.007.
• New cardiovascular prevention guidelines: How to optimally manage dyslipidaemia and cardiovascular risk in 2021 in patients needing secondary prevention? Atar D, Jukema J, Molemans B, et al. Atherosclerosis. 2021 Feb. doi: 10.1016/j.atherosclerosis.2020.12.013.
• Circular RNA in cardiovascular disease: Expression, mechanisms and clinical prospects. Tang Y, Bao J, Hu J, et al. J Cell Mol Med. 2021 Feb. doi: 10.1111/jcmm.16203.
• GDF-15 as a Biomarker in Cardiovascular Disease.  May B, Pimentel M, Zimerman L, et al. Arq Bras Cardiol. 2021 Mar. doi: 10.36660/abc.20200426.
• Molecular Research in Cardiovascular Disease. Dorobantu M, Simionescu M, Popa-Fotea N. Int J Mol Sci. 2021 Jul. doi: 10.3390/ijms22137199.
• Cardiovascular Disease in Breast Cancer Survivors: An Important Topic in Breast Cancer Survivorship. Blaes A, Konety S. J Natl Cancer Inst. 2021 Feb. doi: 10.1093/jnci/djaa097.
• Inflammation: a putative link between phosphate metabolism and cardiovascular disease. Voelkl J, Egli-Spichtig D, Alesutan I, et al. Clin Sci (Lond). 2021 Jan. doi: 10.1042/CS20190895.
• Subjective Aging and Incident Cardiovascular Disease.  Stephan Y, Sutin A, Wurm S, et al. J Gerontol B Psychol Sci Soc Sci. 2021 Apr. doi: 10.1093/geronb/gbaa106.

Sponsored by Pfizer  Inc. 

_{1. Mayo Clinic. (n.d.). Heart Disease. Retrieved from: https://www.mayoclinic.org/diseases-conditions/heart-disease/symptoms-causes/syc-20353118}